| Teva Pharmaceutical Industries Ltd (TEVA) | |||
|---|---|---|---|
| 10.57 0.15 (1.44%) | 05-14 16:00 | ||
| Open: | 10.22 | Pre. Close: | 10.25 |
| High: | 10.65 | Low: | 10.2 |
| Volume: | 8,367,913 | Market Cap: | 12,128M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 10.651 - 10.688 | 10.688 - 10.722 |
| Low: | 10.095 - 10.142 | 10.142 - 10.185 |
| Close: | 10.494 - 10.561 | 10.561 - 10.622 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 12.99 One year: 15.17 |
| Support: | Support1: 10.39 Support2: 9.94 |
| Resistance: | Resistance1: 11.12 Resistance2: 12.99 |
| Pivot: | 10.41 |
| Moving Averages: | MA(5): 10.35 MA(20): 10.36  MA(100): 11.06 MA(250): 10.76 |
| MACD: | MACD(12,26): -0.13 Signal(12,26,9): -0.17 |
| %K %D: | %K(14,3): 51.06 %D(3): 41.33 |
| RSI: | RSI(14): 50.41 |
| 52-Week: | High: 13.3 Low: 8.44 Change(%): -10.2 |
| Average Vol(K): | 3-Month: 863689 10-Days: 872472 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.TEVA has closed below upper band by 30.6%. Bollinger Bands are 48.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to TEVA's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency |  |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency | |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers General Specialty & Generic | |
| Shares Out. (M) | 1100.00 |
| Shares Float (M) | 1100.00 |
| % Held by Insiders | 0.78 |
| % Held by Institutions | 52.18 |
| Shares Short (K) | 29830 |
| Shares Short Prior Month (K) | 36370 |
| Stock Financials | |
|---|---|
| EPS | -3.630 |
| Book Value (p.s.) | 9.070 |
| Profit Margin | -24.45 |
| Operating Margin | 17.61 |
| Return on Assets (ttm) | 3.4 |
| Return on Equity (ttm) | -31.6 |
| Qtrly Rev. Growth | -8.6 |
| Gross Profit (p.s.) | 7.027 |
| Sales Per Share | 14.800 |
| EBITDA (p.s.) | 4.000 |
| Qtrly Earnings Growth | 11.60 |
| Operating Cash Flow (M) | 506.00 |
| Levered Free Cash Flow (M) | 1380.00 |
| Stock Valuation | |
|---|---|
| PE Ratio | -2.91 |
| PEG Ratio | |
| Price to Book value | 1.17 |
| Price to Sales | 0.71 |
| Price to Cash Flow | 22.98 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
